CN111394315A - 表达猪CD163和CD169分子的悬浮Marc145细胞系 - Google Patents
表达猪CD163和CD169分子的悬浮Marc145细胞系 Download PDFInfo
- Publication number
- CN111394315A CN111394315A CN202010179681.8A CN202010179681A CN111394315A CN 111394315 A CN111394315 A CN 111394315A CN 202010179681 A CN202010179681 A CN 202010179681A CN 111394315 A CN111394315 A CN 111394315A
- Authority
- CN
- China
- Prior art keywords
- plasmid
- pb513b
- cells
- marc145
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010179681.8A CN111394315A (zh) | 2020-03-13 | 2020-03-13 | 表达猪CD163和CD169分子的悬浮Marc145细胞系 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010179681.8A CN111394315A (zh) | 2020-03-13 | 2020-03-13 | 表达猪CD163和CD169分子的悬浮Marc145细胞系 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111394315A true CN111394315A (zh) | 2020-07-10 |
Family
ID=71427279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010179681.8A Pending CN111394315A (zh) | 2020-03-13 | 2020-03-13 | 表达猪CD163和CD169分子的悬浮Marc145细胞系 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111394315A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116694575A (zh) * | 2023-08-02 | 2023-09-05 | 上海澳斯康生物制药有限公司 | 悬浮培养Marc145细胞的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190313615A1 (en) * | 2018-04-17 | 2019-10-17 | The Curators Of The University Of Missouri | Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (prrsv) |
CN110373379A (zh) * | 2019-07-25 | 2019-10-25 | 北京鼎持生物技术有限公司 | 一种Marc-145全悬浮细胞直接培养猪蓝耳病病毒疫苗的方法 |
-
2020
- 2020-03-13 CN CN202010179681.8A patent/CN111394315A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190313615A1 (en) * | 2018-04-17 | 2019-10-17 | The Curators Of The University Of Missouri | Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (prrsv) |
CN110373379A (zh) * | 2019-07-25 | 2019-10-25 | 北京鼎持生物技术有限公司 | 一种Marc-145全悬浮细胞直接培养猪蓝耳病病毒疫苗的方法 |
Non-Patent Citations (1)
Title |
---|
吴香菊: "稳定高效表达猪CD163的MARC-145细胞系的构建及其应用" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116694575A (zh) * | 2023-08-02 | 2023-09-05 | 上海澳斯康生物制药有限公司 | 悬浮培养Marc145细胞的方法 |
CN116694575B (zh) * | 2023-08-02 | 2023-12-01 | 上海澳斯康生物制药有限公司 | 悬浮培养Marc145细胞的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107164409B (zh) | 犬瘟热病毒敏感细胞系slam-mdck及其构建方法和应用 | |
CN110468155B (zh) | 一种用于拯救猪肠道甲型冠状病毒的系统、方法及应用 | |
CN111454910A (zh) | 表达猪cd163和cd169分子的悬浮pk15细胞系 | |
CN113061586A (zh) | 表达血清8型禽腺病毒纤突蛋白重组血清4型禽腺病毒以及制备方法 | |
CN111534547A (zh) | 一种表达血清4型禽腺病毒纤突蛋白f2的重组杆状病毒的构建方法 | |
CN116463297A (zh) | 一种表达鸡传染性贫血病病毒vp1蛋白的重组血清4型禽腺病毒及其制备方法 | |
CN113980912B (zh) | 可复制ibv病毒qx亚型毒株的基因敲除细胞系及其构建方法和应用 | |
CN113355292B (zh) | 一种猪圆环病毒基因改造型弱毒株、构建方法及其应用 | |
CN111394315A (zh) | 表达猪CD163和CD169分子的悬浮Marc145细胞系 | |
CN117511888A (zh) | 一种基于CRISPR-Cas9技术的表达鸡传染性贫血病病毒T1P6毒株VP2蛋白的重组血清4型禽腺病毒及其制备方法 | |
CN109055385B (zh) | 一种有效抑制ⅱ型prrsv感染的基因序列及其应用 | |
CN117025640A (zh) | 一种稳定表达犬细小病毒衣壳蛋白vp1与vp2的细胞系及其制备方法 | |
CN111875678B (zh) | 表达猪繁殖与呼吸综合征病毒gp3/gp5/m基因的重组伪狂犬病毒、构建方法和应用 | |
CN110904056B (zh) | 一种传染性支气管炎病毒rH120-YZS1Δ5a及其构建方法和应用 | |
CN114107176A (zh) | 一种稳定表达非洲猪瘟CD2v蛋白的CHO细胞系及其构建方法和应用 | |
CN113416713A (zh) | 一种重组腺病毒的构建及其应用 | |
CN114381437A (zh) | 一种利用可诱导表达狂犬病病毒蛋白的稳定细胞系生产狂犬病病毒假病毒系统的方法 | |
CN112522204A (zh) | 一种重组marc-145细胞及其构建方法和应用 | |
CN112342244B (zh) | 一种表达Furin蛋白的细胞株及其在禽传染性支气管炎病毒培养中的应用 | |
CN115772502B (zh) | 唾液酸转移酶基因缺失的mdck细胞株及构建方法和应用 | |
CN112143756B (zh) | 一种基于AdEasyTM系统的高效重组腺病毒载体的制备方法和应用 | |
CN117363644B (zh) | Vigs沉默效率报告质粒、评价沉默效率的方法及应用 | |
CN115786282A (zh) | 表达鸭3型腺病毒Fiber-2蛋白的重组血清4型禽腺病毒的构建 | |
CN117965569A (zh) | 一种表达prrs病毒gp5-m蛋白的重组病毒及制备方法和应用 | |
CN117050953A (zh) | Cd46蛋白表达受限的细胞在培养猪流感病毒和/或制备猪流感病毒疫苗中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant after: Shiji Biotechnology (Nanjing) Co.,Ltd. Applicant after: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: Shiji Biotechnology (Nanjing) Co.,Ltd. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221206 Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant before: Shiji Biotechnology (Nanjing) Co.,Ltd. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
TA01 | Transfer of patent application right |